chartexchange

KMDA
Kamada Ltd
stockNASDAQ

At CloseNov 19, 2026 3:59:54 PM EST
7.86USD-2.602%(-0.21)158,516
Pre-marketNov 19, 2026 9:25:30 AM EST
7.90USD-2.107%(-0.17)
After-hoursNov 19, 2026 4:00:30 PM EST
7.83USD-0.382%(-0.03)
Loading…
Loading…
454.35M
Healthcare
Drug Manufacturers-Specialty & Generic
HQ
Rehovot, Israel
Previous Close
$8.07
Beta
1.05
52-Week High
$9.35 2026-02-25
52-Week Low
$6.60 2025-11-21
SMA 50
$8.03
SMA 200
$7.99
Avg. Vol 10D
129,587
Avg. Vol 30D
106,565
Avg. Vol 90D
118,596
Relative Vol
1.49
31.65M
1.8000%
4,458
Mar 10, 2027 (110d)
Aug 27, 2026 · $0.170
KMDA Profile

kamada ltd. is focused on plasma-derived protein therapeutics for orphan indications, and has a commercial product portfolio and a robust late-stage product pipeline. the company uses its proprietary platform technology and know-how for the extraction and purification of proteins from human plasma to produce alpha-1 antitrypsin (aat) in a highly-purified, liquid form, as well as other plasma-derived proteins. aat is a protein derived from human plasma with known and newly-discovered therapeutic roles given its immunomodulatory, anti-inflammatory, tissue-protective and antimicrobial properties. the company's flagship product is glassia®, the first and only liquid, ready-to-use, intravenous plasma-derived aat product approved by the u.s. food and drug administration. kamada markets glassia in the u.s. through a strategic partnership with baxter international. in addition to glassia, kamada has a product line of nine other pharmaceutical products that are marketed through distributor

KMDA Performance
PeriodPriceDateChangeBeta
1W8.092026-11-13-2.72%0.479
1M7.852026-10-20+0.26%1.576
3M8.022026-08-20-1.87%1.290
1Y6.682025-11-20+17.81%1.055
2Y5.822024-11-20+35.22%—
5Y5.602021-11-19+40.54%0.712
KMDA Stock Summary

Kamada Ltd (NASDAQ:KMDA) stock price today is $7.87, and today's volume is 158,516. KMDA is down 2.478% today. The 30 day average volume is 106,565. KMDA market cap is $454.35M with 57.73M shares outstanding.